Literature DB >> 2918482

Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.

M Miyamoto1, S Narumi, A Nagaoka, J T Coyle.   

Abstract

The effects of continuous infusion of cholinergic drugs on behavior in normal rats and on impaired acquisition and retention of several behavioral tasks in rats with basal forebrain (BF) lesions were investigated. Physostigmine and oxotremorine were infused continuously with a miniosmotic pump for 3 weeks, and the performance on several different behavioral tasks was examined during the infusion. In normal rats high doses of physostigmine (4 and 8 mg/kg/day s.c.) produced significant changes in general behavior and impaired performance in the Morris water maze. Oxotremorine (0.25-2 mg/kg/day s.c.) had no significant effects on general behavior or cognitive performance in normal rats, although severe cataracts developed at the high dose (4 mg/kg/day). A deficit in motor habituation in rats with BF lesions produced by bilateral injections of ibotenic acid (30 nmol on each side) was improved markedly by the chronic administration of physostigmine (2 mg/kg/day) and oxotremorine (1 mg/kg/day). BF lesions produced severe impairments in acquisition and retention in a passive avoidance task, an active avoidance and the Morris water maze, which was characterized by a marked disruption of retention. The impairment was also ameliorated markedly by the cholinergic drugs, whereas other behavioral impairments were not affected by the drugs. These results indicate that the continuous administration of cholinergic drugs produces a marked improvement of acquisition and retention in rats with BF lesions, and suggest that the impairment in cognitive performance, especially with regard to retention, caused by BF lesions is due to the disruption of the BF-cortical cholinergic pathway.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918482

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.

Authors:  Ludise Malkova; Alan P Kozikowski; Karen Gale
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

4.  Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions.

Authors:  Y Shishido; M Furushiro; S Tanabe; A Taniguchi; S Hashimoto; T Yokokura; S Shibata; T Yamamoto; S Watanabe
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 5.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Neuromodulatory control of neocortical microcircuits with activity-dependent short-term synaptic depression.

Authors:  Bo Cartling
Journal:  J Biol Phys       Date:  2004-09       Impact factor: 1.365

Review 7.  Potential role of muscarinic agonists in Alzheimer's disease.

Authors:  E E Avery; L D Baker; S Asthana
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

8.  Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice.

Authors:  J E Sweeney; E S Bachman; J T Coyle
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Development of plasticity of brain function with repeated trainings and passage of time after basal forebrain lesions in rats.

Authors:  A Nitta; K Hayashi; T Hasegawa; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests.

Authors:  A Ennaceur; K Meliani
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.